Marshall Wace’s Jounce Therapeutics JNCE Stock Holding History
Bought
Maintained
Sold
Other funds holding JNCE
Marshall Wace's JNCE Position: Q3 2022 in Review
Marshall Wace sold out of Jounce Therapeutics (JNCE) in Q3 2022, closing a stake of 39,339 shares — an estimated $119K sold.
Marshall Wace first reported a position in JNCE in Q4 2018 and held it in 8 quarters. The position peaked at $4.13M in Q4 2019. 102 funds tracked by Wall St. Rank hold JNCE as of Q3 2022.
- Marshall Wace reported no remaining Jounce Therapeutics position as of Q3 2022 after selling out during the quarter.
- Marshall Wace sold 39,339 Jounce Therapeutics shares in Q3 2022, an estimated $119K.
- Marshall Wace first reported a position in Jounce Therapeutics in Q4 2018 and held it in 8 quarters.
- Marshall Wace's Jounce Therapeutics position peaked at $4.13M in Q4 2019.
- 102 funds tracked by Wall St. Rank held Jounce Therapeutics as of Q3 2022.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.